4.8 Article

Pharmacogenomic agreement between two cancer cell line data sets

期刊

NATURE
卷 528, 期 7580, 页码 84-+

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/nature15736

关键词

-

资金

  1. Novartis Institutes for BioMedical Research
  2. Wellcome Trust [086357, 102696]
  3. National Institutes of Health [1U54HG006097-01]
  4. Novartis
  5. Dr. Miriam and Sheldon Adelson Medical Research Foundation
  6. Slim Foundation
  7. EMBL-EBI
  8. Wellcome Trust Sanger Institute Post-Doctoral (ESPOD) programme
  9. Cancer Research UK Clinician Scientist Fellowship [A16629]

向作者/读者索取更多资源

Large cancer cell line collections broadly capture the genomic diversity of human cancers and provide valuable insight into anti-cancer drug response. Here we show substantial agreement and biological consilience between drug sensitivity measurements and their associated genomic predictors from two publicly available large-scale pharmacogenomics resources: The Cancer Cell Line Encyclopedia and the Genomics of Drug Sensitivity in Cancer databases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据